• 응용통계연구
• /
• 제32권1호
• /
• pp.161-171
• /
• 2019

일별 최대전력 수요 예측은 국가의 전력 수급운영에 중요한 과제로서 과거부터 다양한 방법들이 끊임없이 연구되어 왔다. 일별 최대전력 수요를 정확히 예측함으로써 발전설비에 대한 일일 운용계획을 작성하고 효율적인 설비 운용을 통해 불필요한 에너지 자원의 소비를 감소하는데 기여할 수 있으며 여름 겨울철 냉난방수요로 인해 발생하는 전력소비 과다로 인한 전력예비율 감소 문제 등에 선제적으로 대비할 수 있는 장점을 가진다. 이러한 일별 최대전력수요 예측을 위하여 본 논문에서는 Seasonal ARIMA, TBATS, Seasonal Reg-ARIMA, NNETAR 모형에 평일, 주말, 특수일에 대한 효과와 온도에 대한 영향을 함께 고려하여 다음날의 일별 최대전력을 예측하는 모형을 연구하였다. 본 논문을 통한 모형들의 예측 성능 평가 결과 요일, 온도를 고려할 수 있는 Seasonal Reg-ARIMA 모형과 NNETAR 모형이 이를 고려할 수 없는 다른 시계열 모형보다 우수한 예측 성능을 나타내었고 그 중 인공신경망을 활용한 NNETAR 모형의 예측 성능이 가장 우수하였다.

• Korean Journal of Radiology
• /
• 제22권2호
• /
• pp.213-224
• /
• 2021

Objective: Clinical outcomes of patients who undergo transarterial chemoembolization (TACE) for single small hepatocellular carcinoma (HCC) are not consistent, and may differ based on certain imaging findings. This retrospective study was aimed at determining the efficacy of pre-TACE CT or MR imaging findings in predicting survival outcomes in patients with small HCC upon being treated with TACE. Besides, the study proposed to build a risk prediction model for these patients. Materials and Methods: Altogether, 750 patients with functionally good hepatic reserve who received TACE as the first-line treatment for single small HCC between 2004 and 2014 were included in the study. These patients were randomly assigned into training (n = 525) and validation (n = 225) sets. Results: According to the results of a multivariable Cox analysis, three pre-TACE imaging findings (tumor margin, tumor location, enhancement pattern) and two clinical factors (age, serum albumin level) were selected and scored to create predictive models for overall, local tumor progression (LTP)-free, and progression-free survival in the training set. The median overall survival time in the validation set were 137.5 months, 76.1 months, and 44.0 months for low-, intermediate-, and high-risk groups, respectively (p < 0.001). Time-dependent receiver operating characteristic curves of the predictive models for overall, LTP-free, and progression-free survival applied to the validation cohort showed acceptable areas under the curve values (0.734, 0.802, and 0.775 for overall survival; 0.738, 0.789, and 0.791 for LTP-free survival; and 0.671, 0.733, and 0.694 for progression-free survival at 3, 5, and 10 years, respectively). Conclusion: Pre-TACE CT or MR imaging findings could predict survival outcomes in patients with small HCC upon treatment with TACE. Our predictive models including three imaging predictors could be helpful in prognostication, identification, and selection of suitable candidates for TACE in patients with single small HCC.